Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Mega Doctor News CLEVELAND CLINIC A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live longer and face fewer serious health problems compared with those treated with GLP-1 receptor agonist medicines alone
Given the challenges many patients experience in achieving their target blood sugar goals, todays approval of Mounjaro is an important advance in the treatment of type 2 diabetes, he said
Beyond Weight Loss: The Clinical Frontier While public attention focuses on weight loss results, researchers are uncovering a much broader range of potential benefits: Cardiovascular Protection : Recent large-scale studies have demonstrated significant reductions in major adverse cardiovascular events among GLP-1 usersbenefits that extend beyond what would be expected from weight loss alone
demonstrated that GLP-1RAs positively regulate adiponectin levels, potentially improving sepsis outcomes by modulating both metabolic homeostasis and inflammatory responses
2021;320:H1486-1497
